US Stock MarketDetailed Quotes

Kiniksa Pharmaceuticals International (KNSA)

Watchlist
  • 59.480
  • +1.110+1.90%
Close May 12 16:00 ET
4.58BMarket Cap65.36P/E (TTM)

Kiniksa Pharmaceuticals International (KNSA) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Product revenue, net214.27M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States676.75M99.88%
United Kingdom814K0.12%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More